Editorial: New molecular approaches to improve gynecological cancer management

Front Oncol. 2023 Jun 21:13:1235035. doi: 10.3389/fonc.2023.1235035. eCollection 2023.

Miguel Henriques Abreu^{1

2}, Gabriella Lillsunde-Larsson^{3

4}, Carla Bartosch^{2

5

6}, Sara Ricardo^{7

8

9}

¹ Department of Medical Oncology, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.
² Porto Comprehensive Cancer Center Raquel Seruca (PCCC), Porto, Portugal.
³ Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
⁴ School of Health Sciences, Örebro University, Örebro, Sweden.
⁵ Department of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.
⁶ Cancer Biology & Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (CI-IPO-Porto)/Health Research Network (RISE@CI-IPO-Porto), Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.
⁷ Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, Porto, Portugal.
⁸ 1H-TOXRUN - One Health Toxicology Research Unit, University Institute of Health Sciences (IUCS), CESPU, CRL, Gandra, Portugal.
⁹ Department of Pathology, Faculty of Medicine from University of Porto (FMUP), Porto, Portugal.

No abstract available

Keywords: cervical cancer; endometrial cancer; gynecology oncology; ovarian cancer; vaginal cancer; vulvar cancer.

Publication types